| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Biochemistry & Molecular Biology, Center for Diabetes Research, Indiana University School of Medicine, Indianapolis, Indiana 46202
Address all correspondence and requests for reprints to: Debbie C. Thurmond, Ph.D., Department of Biochemistry & Molecular Biology, Center for Diabetes Research, Indiana University School of Medicine, Indianapolis, Indiana 46202. E-mail: dthurmon{at}iupui.edu.
Numerous overexpression studies have recently implicated Syntaxin 4 as an effector of insulin secretion, although its requirement in insulin granule exocytosis is unknown. To address this, islets from Syntaxin 4 heterozygous (/+) knockout mice were isolated and compared with islets from wild-type mice. Under static incubation conditions, Syntaxin 4 (/+) islets showed a 60% reduction in glucose-stimulated insulin secretion compared with wild-type islets. Perifusion analyses revealed that Syntaxin 4 (/+) islets secreted 50% less insulin during the first phase of glucose-stimulated insulin secretion and that this defect could be fully restored by the specific replenishment of recombinant Syntaxin 4. This essential role for Syntaxin 4 in secretion from the islet was localized to the ß-cells because small interfering RNA-mediated depletion of Syntaxin 4 in MIN6 ß-cells abolished glucose-stimulated insulin secretion. Moreover, immunofluorescent confocal microscopy revealed that Syntaxin 4 was principally localized to the ß-cells and not the
-cells of the mouse islet. Remarkably, islets isolated from transgenic mice that express 2.4-fold higher levels of Syntaxin 4 relative to wild-type mice secreted approximately 35% more insulin during both phases of insulin secretion, suggesting that increased Syntaxin 4 may be beneficial for enhancing biphasic insulin secretion in a regulated manner. Taken together, these data support the notion that Syntaxin 4-based SNARE complexes are essential for biphasic insulin granule fusion in pancreatic ß-cells.
This article has been cited by other articles:
![]() |
J. L. Jewell, E. Oh, S. M. Bennett, S. O. Meroueh, and D. C. Thurmond The Tyrosine Phosphorylation of Munc18c Induces a Switch in Binding Specificity from Syntaxin 4 to Doc2{beta} J. Biol. Chem., August 1, 2008; 283(31): 21734 - 21746. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Eliasson, F. Abdulkader, M. Braun, J. Galvanovskis, M. B. Hoppa, and P. Rorsman Novel aspects of the molecular mechanisms controlling insulin secretion J. Physiol., July 15, 2008; 586(14): 3313 - 3324. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Jewell, W. Luo, E. Oh, Z. Wang, and D. C. Thurmond Filamentous Actin Regulates Insulin Exocytosis through Direct Interaction with Syntaxin 4 J. Biol. Chem., April 18, 2008; 283(16): 10716 - 10726. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Min, Y. M. Leung, A. Tomas, R. T. Watson, H. Y. Gaisano, P. A. Halban, J. E. Pessin, and J. C. Hou Dynamin Is Functionally Coupled to Insulin Granule Exocytosis J. Biol. Chem., November 16, 2007; 282(46): 33530 - 33536. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Oh, C. J. Heise, J. M. English, M. H. Cobb, and D. C. Thurmond WNK1 Is a Novel Regulator of Munc18c-Syntaxin 4 Complex Formation in Soluble NSF Attachment Protein Receptor (SNARE)-mediated Vesicle Exocytosis J. Biol. Chem., November 9, 2007; 282(45): 32613 - 32622. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ke, E. Oh, and D. C. Thurmond Doc2beta Is a Novel Munc18c-interacting Partner and Positive Effector of Syntaxin 4-mediated Exocytosis J. Biol. Chem., July 27, 2007; 282(30): 21786 - 21797. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ohara-Imaizumi, T. Fujiwara, Y. Nakamichi, T. Okamura, Y. Akimoto, J. Kawai, S. Matsushima, H. Kawakami, T. Watanabe, K. Akagawa, et al. Imaging analysis reveals mechanistic differences between first- and second-phase insulin exocytosis J. Cell Biol., May 21, 2007; 177(4): 695 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, E. Oh, and D. C. Thurmond Glucose-stimulated Cdc42 Signaling Is Essential for the Second Phase of Insulin Secretion J. Biol. Chem., March 30, 2007; 282(13): 9536 - 9546. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. O'Driscoll, P. Gammell, E. McKiernan, E. Ryan, P. B. Jeppesen, S. Rani, and M. Clynes Phenotypic and global gene expression profile changes between low passage and high passage MIN-6 cells J. Endocrinol., December 1, 2006; 191(3): 665 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Nevins and D. C. Thurmond Caveolin-1 Functions as a Novel Cdc42 Guanine Nucleotide Dissociation Inhibitor in Pancreatic beta-Cells J. Biol. Chem., July 14, 2006; 281(28): 18961 - 18972. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |